SCRUBTEAM SURGICAL SPONGEBRUSH
Clinical safety rating: caution
Comprehensive clinical and safety monograph for SCRUBTEAM SURGICAL SPONGEBRUSH (SCRUBTEAM SURGICAL SPONGEBRUSH).
Physical removal of microorganisms and debris through mechanical friction combined with the antiseptic action of 1% betadine (povidone-iodine), which oxidizes proteins and DNA of microbial cells, causing cell death.
| Metabolism | Not applicable; topical antiseptic with no systemic absorption. |
| Excretion | Not systemically absorbed; active ingredient (chlorhexidine gluconate) is not excreted via renal or hepatic routes. Eliminated primarily through desquamation of skin cells and washing off. No renal or biliary excretion occurs. |
| Half-life | Not applicable; chlorhexidine gluconate exhibits prolonged skin binding without systemic absorption. Terminal half-life in plasma is not measurable due to negligible systemic levels. |
| Protein binding | Not applicable; chlorhexidine is not systemically absorbed. At local skin site, it binds to proteins in the stratum corneum, but percentage is not defined clinically. |
| Volume of Distribution | Not applicable; chlorhexidine is not absorbed into systemic circulation. Volume of distribution is not defined for topical application. |
| Bioavailability | Negligible (<0.1%) via intact skin; systemic absorption is minimal. Bioavailability via oral or mucous membrane routes is not relevant for this product. |
| Onset of Action | Immediate upon scrubbing; chlorhexidine binds to skin within seconds, providing rapid antimicrobial activity within 30 seconds. |
| Duration of Action | Substantive effect persists for up to 6 hours after application due to binding to stratum corneum; residual activity diminishes with hand washing or alcohol-based hand rubs. |
Scrub for 2-3 minutes using spongebrush with 4% chlorhexidine gluconate or 7.5% povidone-iodine, then rinse. Apply to surgical site; no systemic dosing.
| Dosage form | SPONGE |
| Renal impairment | No dosage adjustment required for topical use. |
| Liver impairment | No dosage adjustment required for topical use. |
| Pediatric use | Use as directed; scrub for 2-3 minutes with sponge, avoiding prolonged contact. Not recommended for infants <2 months due to skin sensitivity. |
| Geriatric use | Use as directed; monitor skin integrity due to thinner skin. No dose adjustment needed. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for SCRUBTEAM SURGICAL SPONGEBRUSH (SCRUBTEAM SURGICAL SPONGEBRUSH).
| Breastfeeding | Compatible with breastfeeding. Chlorhexidine has negligible systemic absorption; M/P ratio not applicable. |
| Teratogenic Risk | Scrubteam Surgical Spongebrush contains chlorhexidine gluconate. No teratogenic risk in humans; systemic absorption negligible. No known fetal risk across trimesters due to minimal absorption. |
| Fetal Monitoring |
■ FDA Black Box Warning
None.
| Serious Effects |
["Known hypersensitivity to iodine or other components of the product"]
| Precautions | ["For external use only; avoid contact with eyes, ears, and mouth.","May cause skin irritation or allergic reactions in sensitive individuals.","Do not use on compromised skin or open wounds.","Discontinue if irritation or rash develops."] |
Loading safety data…
| No specific maternal or fetal monitoring required. Use on intact skin only; avoid contact with eyes, ears, mouth, and wounds. |
| Fertility Effects | No known effects on fertility. Topical application with negligible systemic absorption. |